A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To ascertain the effect of thalidomide on immune responses to vaccination with polyvalent
pneumococcal polysaccharide vaccine and tetanus toxoid in HIV-infected patients;
particularly, on markers of immune activation and parameters of specific, anti-HIV cellular
immunity.